ArticleJournal for immunotherapy of cancer2023

Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma.

Meenal Sinha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.